NovoCIB Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 3


  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $236K

  • Investors
  • 1

NovoCIB General Information


Developer of innovative enzyme activity assay kits intended for life scientists and for food quality control. The company produces recombinant enzymes of purine metabolism and also provides analytical services for nucleotide quantification, enabling the food industry with rich sources of validated or high-potential targets in oncology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Corporate Office
  • 2, rue Solferino
  • 62200 Boulogne-sur-Mer
  • France
+33 03 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovoCIB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 03-Nov-2014 $236K 00000 00.000 Completed Generating Revenue
1. Angel (individual) 01-Nov-2012 00000 00000 00.00 Completed Generating Revenue
To view NovoCIB’s complete valuation and funding history, request access »

NovoCIB Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares 00,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary Shares 00,000 00.000000 00.00 00.00 00 00.00 00.000
To view NovoCIB’s complete cap table history, request access »

NovoCIB Executive Team (2)

Name Title Board Seat Contact Info
Larissa Balakireva Co-Founder, Chief Executive Officer and President
Nicolas Godard General Manager
To view NovoCIB’s complete executive team members history, request access »

NovoCIB Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovoCIB Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Savoie Angels Angel Group Minority 000 0000 000000 0
To view NovoCIB’s complete investors history, request access »


  • When was NovoCIB founded?

    NovoCIB was founded in 2005.

  • Who is the founder of NovoCIB?

    Larissa Balakireva is the founder of NovoCIB.

  • Who is the CEO of NovoCIB?

    Larissa Balakireva is the CEO of NovoCIB.

  • Where is NovoCIB headquartered?

    NovoCIB is headquartered in Boulogne-sur-Mer, France.

  • What is the size of NovoCIB?

    NovoCIB has 3 total employees.

  • What industry is NovoCIB in?

    NovoCIB’s primary industry is Biotechnology.

  • Is NovoCIB a private or public company?

    NovoCIB is a Private company.

  • What is the current valuation of NovoCIB?

    The current valuation of NovoCIB is 00.000.

  • What is NovoCIB’s current revenue?

    The current revenue for NovoCIB is 00000.

  • How much funding has NovoCIB raised over time?

    NovoCIB has raised $495K.

  • Who are NovoCIB’s investors?

    Savoie Angels has invested in NovoCIB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »